Uniform Biological Material Transfer Agreement – MTA

Definitions

1. PROVIDER: Organization providing the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
2. PROVIDER SCIENTIST: The name and address of this party will be specified in an implementing letter.
3. RECIPIENT: Organization receiving the ORIGINAL MATERIAL. The name and address of this party will be specified in an implementing letter.
4. RECIPIENT SCIENTIST: The name and address of this party will be specified in an implementing letter.
5. ORIGINAL MATERIAL: The description of the material being transferred will be specified in an implementing letter.
6. MATERIAL: ORIGINAL MATERIAL, and PROGENY. The MATERIAL shall not include: (a) MODIFICATIONS, or (b) other substances created by the RECIPIENT through the use of the MATERIAL which are not MODIFICATIONS, PROGENY, or UNMODIFIED DERIVATIVES.
7. PROGENY: Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism, DNA/RNA duplicated by DNA/RNA supplied by the PROVIDER, purified or fractionated subsets of the ORIGINAL MATERIAL.
8. UNMODIFIED DERIVATIVES: Substances created by the RECIPIENT which constitute an unmodified functional subunit or product expressed by the ORIGINAL MATERIAL. Some examples include: proteins expressed by DNA/RNA supplied by the PROVIDER, or monoclonal antibodies secreted by a hybridoma cell line.
9. MODIFICATIONS: Substances created by the RECIPIENT which contain/incorporate the MATERIAL, and UNMODIFIED DERIVATIVES.
10. COMMERCIAL PURPOSES: The sale, lease, license, or other transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. COMMERCIAL PURPOSES shall also include uses of the MATERIAL or MODIFICATIONS by any organization, including RECIPIENT, to perform contract research, to screen compound libraries, to produce or manufacture products for general sale, or to conduct research activities that result in any sale, lease, license, or transfer of the MATERIAL or MODIFICATIONS to a for-profit organization. However, industrially sponsored academic research shall not be considered a use of the MATERIAL or MODIFICATIONS for COMMERCIAL PURPOSES per se, unless any of the above conditions of this definition are met.
11. NONPROFIT ORGANIZATION(S): A university or other institution of higher education or an organization any nonprofit scientific or educational organization qualified under a nonprofit organization statute. As used herein, the term also includes government agencies.

Terms and Conditions of this Agreement

1. The PROVIDER retains ownership of the MATERIAL, including any MATERIAL contained or incorporated in MODIFICATIONS.

2. The RECIPIENT retains ownership of: (a) MODIFICATIONS (except that, the PROVIDER retains ownership rights to the MATERIAL included therein), and (b) those substances created through the use of the MATERIAL or MODIFICATIONS, but which are not PROGENY, UNMODIFIED DERIVATIVES or MODIFICATIONS (i.e., do not contain the ORIGINAL MATERIAL, PROGENY, UNMODIFIED DERIVATIVES). If either 2 (a) or 2 (b) results from the collaborative efforts of the PROVIDER and the RECIPIENT, joint ownership may be negotiated.

a) is to be used solely for teaching and academic research purposes;
b) will not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of the PROVIDER;
c) is to be used only at the RECIPIENT organization and only in the RECIPIENT SCIENTIST's laboratory under the direction of the RECIPIENT SCIENTIST or others working under his/her direct supervision;
d) will not be transferred to anyone else outside the RECIPIENT organization without the prior written consent of the PROVIDER.

4. The RECIPIENT and the RECIPIENT SCIENTIST agree to refer to the PROVIDER any request for the MATERIAL from anyone other than those persons working under the RECIPIENT SCIENTIST's direct supervision. To the extent supplies are available, the PROVIDER or the PROVIDER SCIENTIST agrees to make the MATERIAL available, under a separate implementing letter to this Agreement or other agreement having terms consistent with the terms of this Agreement, to other scientists (at least those at NONPROFIT ORGANIZATION(S)) who wish to replicate the RECIPIENT SCIENTIST's research; provided that such other scientists reimburse the PROVIDER for any costs relating to the preparation and distribution of the MATERIAL.

a) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute substances created by the PROVIDER through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
b) Under a separate implementing letter to this Agreement (or an agreement at least as protective of the PROVIDER's rights), the RECIPIENT and/or the RECIPIENT SCIENTIST may distribute substances created by the RECIPIENT through the use of the ORIGINAL MATERIAL only if those substances are not PROGENY, UNMODIFIED DERIVATIVES, or MODIFICATIONS.
c) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS to NONPROFIT ORGANIZATION(S) for research and teaching purposes only.
d) The PROVIDER and/or the PROVIDER SCIENTIST shall have the right, without restriction, to distribute MATERIAL for COMMERCIAL PURPOSES. It is recognized by the PROVIDER that such COMMERCIAL PURPOSES may NOT require a commercial license from the RECIPIENT and the RECIPIENT has no obligation to grant a commercial license to its ownership interest in the MATERIAL. Nothing in this paragraph, however, shall prevent the PROVIDER from granting commercial licenses under the PROVIDER's intellectual property rights claiming such MATERIAL, or methods of their manufacture or their use.
e) The RECIPIENT and/or the RECIPIENT SCIENTIST shall have the right, without restriction, to distribute MODIFICATIONS for COMMERCIAL PURPOSES. It is recognized by the RECIPIENT that such COMMERCIAL PURPOSES may NOT require a commercial license from the PROVIDER and the PROVIDER has no obligation to grant a commercial license to its ownership interest in the MATERIAL incorporated in the MODIFICATIONS. Nothing in this paragraph, however, shall prevent the RECIPIENT from granting commercial licenses under the RECIPIENT's intellectual property rights claiming such MODIFICATIONS, or methods of their manufacture or their use.

6. The RECIPIENT acknowledges that the MATERIAL is or may be the subject of a patent application. Except as provided in this Agreement, no express or implied licenses or other rights are provided to the RECIPIENT under any patents, patent applications, trade secrets or other proprietary rights of the PROVIDER, including any altered forms of the MATERIAL made by the PROVIDER. In particular, no express or implied licenses or other rights are provided to use the MATERIAL, MODIFICATIONS, or any related patents of the PROVIDER for COMMERCIAL PURPOSES.

7. If the RECIPIENT desires to use or license the MATERIAL for COMMERCIAL PURPOSES, the RECIPIENT agrees, in advance of such use, to negotiate in good faith with the PROVIDER to establish the terms of a commercial license. It is understood by the RECIPIENT that the PROVIDER shall have no obligation to grant such a license to the RECIPIENT, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MATERIAL to any third party(ies), subject to any pre-existing rights held by others and obligations to the Federal Government.

8. If the PROVIDER desires to use or license the MODIFICATIONS for COMMERCIAL PURPOSES, the PROVIDER agrees, in advance of such use, to negotiate in good faith with the RECIPIENT to establish the terms of a commercial license. It is understood by the PROVIDER that the RECIPIENT shall have no obligation to grant such a license to the PROVIDER, and may grant exclusive or non-exclusive commercial licenses to others, or sell or assign all or part of the rights in the MODIFICATIONS to any third party(ies), subject to any pre-existing rights held by others and obligations to theGovernment.

9. The PROVIDER is free to file patent application(s) claiming inventions made by the PROVIDER through the use of the MODIFICATIONS but agrees to notify the RECIPIENT upon filing a patent application claiming MATERIAL or method(s) of manufacture or use(s) of the MATERIAL.

10. The RECIPIENT is free to file patent application(s) claiming inventions made by the RECIPIENT through the use of the MATERIAL but agrees to notify the PROVIDER upon filing a patent application claiming MODIFICATIONS or method(s) of manufacture or use(s) of the MATERIAL.

11. Any MATERIAL delivered pursuant to this Agreement is understood to be experimental in nature and may have hazardous properties. The PROVIDER MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS.

12. Except to the extent prohibited by law, the RECIPIENT assumes all liability for damages which may arise from its use, storage or disposal of the MATERIAL. The PROVIDER will not be liable to the RECIPIENT for any loss, claim or demand made by the RECIPIENT, or made against the RECIPIENT by any other party, due to or arising from the use of the MATERIAL by the RECIPIENT, except to the extent permitted by law when caused by the gross negligence or willful misconduct of the PROVIDER.

13. This agreement shall not be interpreted to prevent or delay publication of research findings resulting from the use of the MATERIAL or the MODIFICATIONS. The PROVIDER SCIENTIST agrees to provide appropriate acknowledgment of the source of the MODIFICATIONS in all publications. The RECIPIENT SCIENTIST agrees to provide appropriate acknowledgment of the source of the MATERIAL in all publications.

14. The PROVIDER agrees to use the MODIFICATIONS in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA. The RECIPIENT agrees to use the MATERIAL in compliance with all applicable statutes and regulations, including Public Health Service and National Institutes of Health regulations and guidelines such as, for example, those relating to research involving the use of animals or recombinant DNA.

i) if termination should occur under 15(a), the RECIPIENT shall be bound to the PROVIDER by the least restrictive terms applicable to the MATERIAL obtained from the then-available resources; and
ii) if termination should occur under 15(b) or (d) above, the RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS; and
iii) In the event the PROVIDER terminates this Agreement under 15( c) other than for breach of this Agreement or for cause such as an imminent health risk or patent infringement, the PROVIDER will defer the effective date of termination for a period of up to one year, upon request from the RECIPIENT, to permit completion of research in progress. Upon the effective date of termination, or if requested, the deferred effective date of termination, RECIPIENT will discontinue its use of the MATERIAL and will, upon direction of the PROVIDER, return or destroy any remaining MATERIAL. The RECIPIENT, at its discretion, will also either destroy the MODIFICATIONS or remain bound by the terms of this agreement as they apply to MODIFICATIONS.

16.Paragraphs 6, 11 and 12 shall survive termination.

17.The MATERIAL is provided at no cost, or with an optional transmittal fee solely to reimburse the PROVIDER for its preparation and distribution costs. If a fee is requested by the PROVIDER, the amount will be indicated in an implementing letter. Main Text Ends Here.

RECIPIENT: Kangma-Healthcode (Shanghai) Biotech Co. Ltd.
RECIPIENT SCIENTIST: Rongrong Zhan
RECIPIENT ADDRESS: Building 15, Lane 118 Furonghua Road, Shanghai 201321, CHINA
RECIPIENT TEL: 021-58086922
RECIPIENT EMAIL: customer@healthcodon.com

协议说明

提示

阅读并同意隐私协议、MTA和使用条款后进行下一步!

4-WELL Magnetic Rack (15 mL)- OurProteinFactory

4-WELL Magnetic Rack (15 mL)

产品编号

PROTN_MRN4V15000

￥

220.35

规格

Magnetic Rack: 1.5 mL

Magnetic Rack: 15 mL

Magnetic Rack: 50 mL

Magnetic Rack: 50 mL + 15 mL

数量

我们所有的产品都有30天的退货/退款政策保证。请百分百放心地购物。

订单总额超200元包邮

加入购物车

立即下单

产品详情
评论

Document

MULTIPLE SPECIFICATIONS

For Centrifuge Tubes

MAGNETIC BEAD METHOD

产品描述

PRODUCT DESCRIPTION

为小规模生物实验磁珠法分离样品而设计。可用于常见功能性磁珠分

离，纯化蛋白质的磁珠、分离纯化质粒的磁珠等。

Magnetic rack for sample separation by magnetic bead method. It can be used for separation of common functional magnetic beads, magnetic beads for protein purification, magnetic beads for separation of purified plasmids, etc.

4-WELL 1.5ML

FOR 1.5ML CENTRIFUGE TUBES

MAGNETIC BEAD METHOD

COMPACT SIZE

4-WELL 15ML

FOR 15ML CENTRIFUGE TUBES

MAGNETIC BEAD METHOD

COMPACT SIZE

4-WELL 50ML

FOR 50ML CENTRIFUGE TUBES

MAGNETIC BEAD METHOD

COMPACT SIZE

4-WELL 50+15ML

FOR 50+15ML CENTRIFUGE TUBES

MAGNETIC BEAD METHOD

COMPACT SIZE

小巧轻盈，经久耐用

SMALL, LIGHTWEIGHT AND DURABLE

独特的材质，使得磁力架轻

巧之外又经久耐用。

The unique material of the magnetic frame makes it lightweight and durable.

设计合理，操作便捷

REASONABLE DESIGN AND EASY OPERATION

磁场强度高，离心管紧贴磁力架，分离过程

快速高效，节省时间。

The high strength of the magnetic field and the close proximity of the centrifuge tube to the magnetic shelf make the separation process fast, efficient and time-saving.

先进工艺，表面光滑

ADVANCED TECHNOLOGY, SMOOTH SURFACE

*不同规格磁力架采用相同工艺、

材质制作而成。

* Different specifications of magnetic frame are made of the same process and material.

创新设计盗版必究

INNOVATIVE DESIGN, PIRACY WILL NOT GO UNPUNISHED

独有创新设计；多种规格选择、方便使用；

本产品已荣获外观专利证书(专利号：ZL 2019 3 0413738.4)享有专有知识产权。

Unique innovative design; a variety of specifications to choose from, easy to use; this product has been awarded the

Appearance Patent Certificate (Patent No.: ZL 2019 3 0413738.4) to enjoy the exclusive intellectual property rights

操作方法

METHOD OF OPERATION

将结合完毕的装有待分离磁珠-目的物混合液的离心管置于磁力架上。

The combined centrifuge tube containing the bead-target mixture to be separated is placed on a magnetic stand.

静止1分钟，直到磁珠都被吸至离心管壁。

Rest for 1 minute until the beads are sucked into the walls of the centrifuge tube.

小心的倒去液体，或用移液器吸弃液体。

Carefully decant the liquid, or use a pipette to aspirate the liquid.

将离心管从磁力架上取出，放回普通离心管架，即完成了磁分离操作。

The magnetic separation operation is completed by removing the centrifuge tube from the magnetic rack and placing it back into the ordinary centrifuge tube rack.

注意事项

NOTES

磁力架包含强磁场。佩戴心脏起搏器或其他医疗磁场装置者请勿使用。使用时请与钢铁制品保持0.5米以上距离，如刀片，镊子等一定远离磁力架。本品含有可拆卸小型强磁铁，应避免儿童接触，以免发生吞食。

The magnetic cage contains a strong magnetic field. Do not use if you are wearing a pacemaker or other medical magnetic field device. Keep steel objects, such as blades, tweezers, etc., at least 0.5m away from the magnetic holder when in use. This product contains a small, removable, strong magnet that should be kept out of the reach of children to prevent swallowing.

保存与清洁

PRESERVATION AND CLEANING

磁力架包含强力磁铁部件，其磁性可维持终身不会消退。建议保存于凉爽、干燥环境。请勿在超过70℃（122℉）的环境下使用。避免暴露于外加磁场下。避免日光或紫外灯直射，因UV会使其表面变脆弱。可用75%酒精或1%次氯酸钠消毒，消毒后及时擦干，不可浸泡于水或其他液体中。

The magnetic holder contains a strong magnet component that will last a lifetime without fading. It is recommended to store in a cool, dry environment. Do not use in an environment that exceeds 70℃ (122°F). Avoid exposure to an applied magnetic field. Avoid direct sunlight or UV light, as the UV will brittle the surface. Can be disinfected with 75% alcohol or 1% sodium hypochlorite, wipe dry immediately after disinfection, do not immerse in water or other liquids.

FOOT

更多联系方式，上海市浦东新区芙蓉花路118弄12-15号楼，请拨打 +1-800-955 -3390or+86-400-770-5500周一到周日 0:00-24:00

沪公网安备 31011502014489号

中国

Uniform Biological Material Transfer Agreement – MTA

Definitions

Terms and Conditions of this Agreement

PROTEIN FACTORY

PROTEIN FACTORY

SIGN UP

RESET PASSWORD

Successfully Set up!